These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6690065

  • 1. Enhancement of the DNA cross-linking activity of nitrogen mustard by misonidazole and diethyl maleate in a mouse fibrosarcoma tumor in vivo.
    Murray D, Meyn RE.
    Cancer Res; 1984 Jan; 44(1):91-6. PubMed ID: 6690065
    [Abstract] [Full Text] [Related]

  • 2. Effect of misonidazole pretreatment on nitrogen mustard-induced DNA cross-linking in mouse tissues in vivo.
    Murray D, Meyn RE.
    Br J Cancer; 1984 Dec; 50(6):801-8. PubMed ID: 6498077
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
    Murray D, Meyn RE.
    Br J Cancer; 1983 Feb; 47(2):195-203. PubMed ID: 6824567
    [Abstract] [Full Text] [Related]

  • 4. DNA damage in normal and neoplastic mouse tissues after treatment with misonidazole in vivo.
    Murray D, Meyn RE.
    Biochem Pharmacol; 1985 Sep 15; 34(18):3275-9. PubMed ID: 4038336
    [Abstract] [Full Text] [Related]

  • 5. Studies on the mechanism of chemosensitization by misonidazole in vitro.
    Taylor YC, Bump EA, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Sep 15; 8(3-4):705-8. PubMed ID: 7107402
    [Abstract] [Full Text] [Related]

  • 6. Radiosensitization by hypoxic pretreatment with misonidazole: an interaction of damage at the DNA level.
    Taylor YC, Evans JW, Brown JM.
    Radiat Res; 1987 Mar 15; 109(3):364-73. PubMed ID: 3550868
    [Abstract] [Full Text] [Related]

  • 7. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.
    Ross WE, Ewig RA, Kohn KW.
    Cancer Res; 1978 Jun 15; 38(6):1502-6. PubMed ID: 565677
    [Abstract] [Full Text] [Related]

  • 8. The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles.
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Jun 15; 8(3-4):675-82. PubMed ID: 7050043
    [Abstract] [Full Text] [Related]

  • 9. Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo.
    DeNeve WJ, Everett CK, Suminski JE, Valeriote FA.
    Cancer Res; 1988 Nov 01; 48(21):6002-5. PubMed ID: 2844397
    [Abstract] [Full Text] [Related]

  • 10. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY, Workman P.
    Br J Cancer; 1983 May 01; 47(5):659-69. PubMed ID: 6849803
    [Abstract] [Full Text] [Related]

  • 11. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
    Mulcahy RT, Dembs N.
    Cancer Res; 1983 Aug 01; 43(8):3539-43. PubMed ID: 6861127
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of melphalan crosslink enhancement by misonidazole pretreatment.
    Taylor YC, Sawyer JM, Hsu B, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Sep 01; 10(9):1603-7. PubMed ID: 6480448
    [Abstract] [Full Text] [Related]

  • 13. Cell cycle-dependent cytotoxicity of alkylating agents: determination of nitrogen mustard-induced DNA cross-links and their repair in Chinese hamster ovary cells synchronized by centrifugal elutriation.
    Murray D, Meyn RE.
    Cancer Res; 1986 May 01; 46(5):2324-9. PubMed ID: 3697977
    [Abstract] [Full Text] [Related]

  • 14. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L, Ito H, Hunter N.
    Cancer Res; 1983 Jul 01; 43(7):3050-6. PubMed ID: 6303574
    [Abstract] [Full Text] [Related]

  • 15. The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells.
    Ramonas LM, Erickson LC, McManus ME.
    Mol Pharmacol; 1982 Jul 01; 22(1):175-81. PubMed ID: 7121448
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing the chemosensitization of melphalan by misonidazole.
    Randhawa VS, Stewart FA, Denekamp J, Stratford MR.
    Br J Cancer; 1985 Feb 01; 51(2):219-28. PubMed ID: 3966979
    [Abstract] [Full Text] [Related]

  • 17. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.
    Lee FY, Workman P.
    Cancer Chemother Pharmacol; 1986 Feb 01; 17(1):30-7. PubMed ID: 3698174
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM, Dionet C, Brown JM.
    Radiat Res; 1984 Jan 01; 97(1):162-70. PubMed ID: 6229806
    [Abstract] [Full Text] [Related]

  • 19. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
    Twentyman PR.
    Cancer Clin Trials; 1980 Jan 01; 3(3):253-6. PubMed ID: 7438322
    [Abstract] [Full Text] [Related]

  • 20. [Recent advances in hypoxic cell radiosensitizer].
    Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M.
    Gan No Rinsho; 1983 Oct 01; 29(13):1608-12. PubMed ID: 6230470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.